Safety Study of Regorafenib and SIR-Spheres® Microspheres Radioembolization in Patients With Refractory Metastatic Colorectal Cancer With Liver Metastases

NCT02195011 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

26

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Neoplasms

Interventions

DEVICE: SIR-Spheres
DRUG: Regorafenib

Sponsor

SCRI Development Innovations, LLC

Collaborators

[object Object]